Coltac Therapeutics
Fast-tracking the future of Molecular Glues
- Employees
- 1–10
- Business Model
- B2B
- Website
- coltactx.com
- Last Round
- SeedJan 2025
- Rounds
- 1
About
Biotech company discovering next-generation molecular glues for protein degradation using bacteria-based synthetic screening platform.
Summary
Coltac Therapeutics is a Biotech company. Its most recent funding was a Seed round in Jan 2025. Investors include aMoon and Israel Biotech Fund.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.